Clinical Trials Browser

Unknown × Pathologic Complete Response × Other hematologic neoplasm × Clear all

NCT03417427 2020-04-27

A Clinical Trail of Demethylation Drug Combined With Chemotherapy in Intermediate-risk AML

Phase 2 Unknown

Other hematologic neoplasm

Pathologic Complete Response, Leukemia, Myeloid, Leukemia, Myeloid, Acute

NCT01520558 2017-06-29

CNDO-109-AANK for AML in First Complete Remission (CR1)

Phase 1/2 Unknown

12 enrolled 11 charts

Other hematologic neoplasm

Pathologic Complete Response, Leukemia, Myeloid, Acute